COGNIZANT CORP
10-Q, 1997-05-13
COMPUTER PROCESSING & DATA PREPARATION
Previous: T F PURIFINER INC, 10QSB, 1997-05-13
Next: ACNIELSEN CORP, 10-Q, 1997-05-13



                                                                            

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549


                                    FORM 10-Q

(Mark one)

(X)        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                  THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 1997

                                       OR

( )        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                  THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                       to
                              ---------------------        ----------------

                        Commission file number 001-12275


                             COGNIZANT CORPORATION
- - --------------------------------------------------------------------------
           (Exact name of registrant as specified in its charter)

           Delaware                                    06-1450569
- - --------------------------------------     ----------------------------------
- - --------------------------------------     ----------------------------------
   (State of Incorporation)               (I.R.S. Employer Identification No.)

 200 Nyala Farms, Westport, CT                           06880
- - --------------------------------------     -----------------------------------
- - --------------------------------------     -----------------------------------
(Address of principal executive offices)               (Zip Code)

Registrant's telephone number, including area code   (203) 222-4200
                                                     --------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by  Sections  13 or 15(d)  of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past 90 days. Yes X No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:
                                                       Shares Outstanding
                     Title of Class                    at March 31, 1997
                     Common Stock,                         167,457,411
                par value $.01 per share


<PAGE>


                              COGNIZANT CORPORATION

                               INDEX TO FORM 10-Q



PART I. FINANCIAL INFORMATION                                        PAGE(S)

Item 1. Financial Statements
Condensed Consolidated Statements of Income (Unaudited)
     Three Months Ended March 31, 1997 and 1996                         3

Condensed Consolidated Statements of Financial Position (Unaudited)
     March 31, 1997 and December 31, 1996                               4

Condensed Consolidated Statements of Cash Flows (Unaudited)
     Three Months Ended March 31, 1997 and 1996                         5


Notes to Condensed Consolidated Financial Statements (Unaudited)      6-8

Item 2. Management's Discussion and Analysis of Financial
            Condition and Results of Operations                       9-11



PART II.  OTHER INFORMATION

Item 6. Exhibits and Reports on Form 8-K                              12

SIGNATURES                                                            13







                                                       -2-
<PAGE>
<TABLE>

PART I. FINANCIAL INFORMATION
Item I. FINANCIAL STATEMENTS

COGNIZANT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
(Dollar amounts in thousands, except per share data)

<CAPTION>
                                                               Three Months Ended
                                                                     March 31,
                                                   -------------------------------------------
<S>                                                          <C>                        <C>
                                                         1997                       1996
                                                   ----------------           ----------------

Operating Revenue                                    $   434,701                $  370,019

Operating Costs                                          193,116                   160,544

Selling and Administrative Expenses                      126,846                   117,168

Depreciation and  Amortization                            37,492                    33,329
                                                   ----------------           ----------------
                                                          77,247                    58,978

Interest Income                                            5,370                     2,087
Interest Expense                                            (450)                     (268)
Other Expense - Net                                       (4,365)                   (1,373)
                                                   ----------------           ----------------
Non-Operating Income - Net                                   555                       446

Income Before Provision for Taxes                         77,802                    59,424

Provision for Income Taxes                               (24,897)                  (26,147)

                                                   ---------------           ----------------
Net Income                                          $     52,905              $     33,277
                                                   ===============           ================



Earnings Per Share of Common Stock                        $.31                      $.20
                                                    =============            ================



Average Number of Shares Outstanding                 169,770,000               169,669,000
                                                    =============           ================




<FN>
See accompanying notes to the condensed consolidated financial statements
(unaudited)
</FN>
                                                       -3-
</TABLE>

<PAGE>
<TABLE>
COGNIZANT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited)
(Dollar amounts in thousands)
<CAPTION>
                                                        March 31,              December 31,
                                                          1997                     1996
                                                -------------------       --------------------
<S>                                                          <C>                      <C>
Assets

Current Assets
   Cash and Cash Equivalents                        $    366,005               $    428,520
   Accounts Receivable-Net                               457,699                    453,791
   Other Current Assets                                  119,119                    112,151
                                                    -------------             -----------------
       Total Current Assets                              942,823                    994,462
                                                    -------------             -----------------
Investments                                              121,400                    117,706
                                                    -------------             -----------------
Property, Plant and Equipment-Net                        267,373                    268,888
                                                    --------------            ----------------
Other Assets-Net
   Computer Software                                     141,028                    139,040
   Goodwill                                              247,585                    251,483
   Other Assets                                          100,517                    103,403
                                                   ---------------             ----------------
       Total Other Assets-Net                            489,130                    493,926
                                                   ---------------             ----------------

Total Assets                                       $   1,820,726               $  1,874,982
                                                  ================            =================

Liabilities and Shareholders' Equity

Current Liabilities
   Accounts and Notes Payable                     $       63,890              $      46,923
   Accrued and Other Current Liabilities                 237,111                    276,682
   Accrued Income Taxes                                   67,670                     63,416
   Deferred Revenues                                     339,371                    292,970
                                                   --------------               --------------
       Total Current Liabilities                         708,042                    679,991
Postretirement and Postemployment Benefits                52,958                     50,519
Deferred Income Taxes                                     88,437                    105,074
Other Liabilities and Minority Interests                 180,002                    166,785
                                                  ---------------               --------------

Total Liabilities                                      1,029,439                  1,002,369
                                                  ---------------               -------------

Shareholders' Equity                                     791,287                    872,613
                                                  ---------------               -------------

Total Liabilities and Shareholders' Equity        $    1,820,726              $   1,874,982
                                                  ================            ===============








<FN>
See  accompanying  notes  to the  condensed  consolidated  financial  statements
(unaudited).
</FN>
                                                       -4-
</TABLE>

<PAGE>
<TABLE>

COGNIZANT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(Dollar amounts in thousands)
<CAPTION>
                                                                 Three Months Ended
                                                                        March 31,
                                                          ------------------------------
                                                                1997             1996
                                                           ------------    --------------
<S>                                                              <C>             <C>
Cash Flows from Operating Activities:
Net Income                                                  $  52,905       $    33,277
Reconciliation of Net Income to Net Cash
  Provided by Operating Activities:
    Depreciation and Amortization                              37,492            33,329
    Gains from Sale of Investments                             (5,436)                -
    Restructuring Payments                                          -            (8,663)
    Postemployment Benefits Expense                                 -             1,667
    Postemployment Benefits Payments                           (3,157)           (5,534)
    Payments Related to 1995 Non-recurring Charge              (2,180)                -
    Net (Increase) Decrease in Accounts Receivable            (27,416)           41,404
    Net Increase in Deferred Revenues                          49,862            16,094
    Gartner Minority Interest Expense                           9,038             5,139
    Deferred Income Taxes                                     (12,975)           26,638
    Net Increase (Decrease) in Accrued Income Taxes             3,095            (3,663)
    Net (Increase) in Other Working Capital Items             (12,297)          (60,288)
- - -----------------------------------------------------------------------------------------
Net Cash Provided by Operating Activities                      88,931            79,400
- - -----------------------------------------------------------------------------------------

Cash Flows from Investing Activities:
Proceeds from Maturities of Marketable Securities               6,355            10,454
Payments for Marketable Securities                             (9,734)          (32,143)
Payments for Acquisitions of Businesses                        (4,762)                -
Proceeds from Sale of  Investment                               7,004                 -
Capital Expenditures                                          (18,586)          (14,909)
Additions to Computer Software                                (16,348)          (10,415)
Additions to Deferred Charges                                  (5,706)          (11,033)
(Increase) Decrease in Investments                            (15,601)            1,367
Other                                                           6,807            (2,544)
- - ----------------------------------------------------------------------------------------
Net Cash Used in Investing Activities                         (50,571)          (59,223)
- - ----------------------------------------------------------------------------------------

Cash Flows from Financing Activities:
Payments for Purchase of Treasury Shares                     (95,069)                -
Proceeds from Exercise of  Stock Options                       1,151                 -
Payments of Dividends                                         (5,117)                -
Other Stock Transactions with Employees                        5,728             8,853
Net Transfers to The Dun & Bradstreet Corporation                  -           (25,591)

Other                                                           (324)           (2,265)
- - ----------------------------------------------------------------------------------------
Net Cash Used in Financing Activities                        (93,631)          (19,003)
- - ----------------------------------------------------------------------------------------

Effect of Exchange Rate Changes on Cash and Cash Equivalents  (7,244)             (607)
- - ----------------------------------------------------------------------------------------

(Decrease) Increase in Cash and Cash Equivalents             (62,515)              567
Cash and Cash Equivalents, Beginning of Year                 428,520           157,105
- - ----------------------------------------------------------------------------------------
Cash and Cash Equivalents, End of Period                   $ 366,005        $  157,672
========================================================================================



<FN>
See  accompanying  notes  to the  condensed  consolidated  financial  statements
(unaudited).
</FN>
</TABLE>
   
                                                  -5-

<PAGE>

COGNIZANT CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Dollar amounts in thousands - (Unaudited)

Note 1- Interim Consolidated Financial Statements

These interim consolidated financial statements have been prepared in accordance
with the  instructions  to Form 10-Q and should be read in conjunction  with the
consolidated  financial  statements  and related notes of Cognizant  Corporation
(the  "Company")  in the 1996  Annual  Report on Form  10-K.  In the  opinion of
management,  all  adjustments  considered  necessary for a fair  presentation of
financial  position,  results  of  operations  and cash  flows  for the  periods
presented have been included.

Note 2 - Investment Partnership

Two of the Company's subsidiaries  participate in a limited partnership,  one of
which  serves as general  partner.  The  partnership,  which is a  separate  and
distinct  legal  entity,  is in the  business of licensing  database  assets and
computer software.  For financial reporting purposes,  the assets,  liabilities,
results of  operations  and cash flows of the  partnership  are  included in the
Company's consolidated financial statements.

Note 3 - Litigation

The  Company  and  its  subsidiaries  are  involved  in  legal  proceedings  and
litigation  arising  in the  ordinary  course of  business.  In the  opinion  of
management,   the  outcome  of  such  current  legal  proceedings,   claims  and
litigation,  if decided adversely,  could have a material effect on quarterly or
annual  operating  results  or cash  flows  when  resolved  in a future  period.
However, in the opinion of management,  these matters will not materially affect
the Company's consolidated financial position.

In addition,  on July 29, 1996,  Information  Resources,  Inc.  ("IRI")  filed a
complaint in the United States  District Court for the Southern  District of New
York, naming as defendants the Dun & Bradstreet Corporation ("Dun & Bradstreet),
A.C. Nielsen Company and I.M.S.  International,  Inc. ("IMS"), a company that is
owned by the Company (the "IRI Action").

The complaint  alleges various  violations of the United States  antitrust laws,
including  alleged  violations  of  Sections  1 and 2 of the  Sherman  Act.  The
complaint  also alleges a claim of tortious  interference  with a contract and a
claim of tortious interference with a prospective business  relationship.  These
claims relate to the  acquisition by defendants of Survey Research Group Limited
("SRG").  IRI alleges  that SRG violated an alleged  agreement  with IRI when it
agreed to be acquired by the defendants  and that the defendants  induced SRG to
breach that agreement.

IRI's  complaint  alleges  damages in excess of  $350,000,  which amount IRI has
asked to be trebled under the antitrust laws. IRI also seeks punitive damages in
an unspecified amount.

On October 15, 1996,  defendants moved for an order dismissing all claims in the
complaint.  On May 6, 1997 the United  States  District  Court for the  Southern
District  of New York  issued a decision  dismissing  IRI's  claim of  attempted
monopolization  in the United  States,  with leave to replead within sixty days.
The Court denied  defendants' motion with respect to the remaining claims in the
complaint.

In connection with the IRI Action, Dun & Bradstreet, ACNielsen Corporation
("ACNielsen")  (the parent company of A.C. Nielsen Company) and the Company have
entered into an Indemnity and Joint Defense  Agreement (the "Indemnity and Joint
Defense  Agreement")   pursuant  to  which  they  have  agreed  (i)  to  certain
arrangements allocating potential liabilities ("IRI Liabilities") that may

                                                          -6-
<PAGE>
Note 3 - Litigation (continued)
arise out of or in  connection  with the IRI  Action and (ii) to conduct a joint
defense of such action. In particular, the Indemnity and Joint Defense Agreement
provides that ACNielsen will assume  exclusive  liability for IRI Liabilities up
to a maximum  amount to be  calculated  at the time  such  liabilities,  if any,
become  payable  (the "ACN  Maximum  Amount"),  and that the  Company  and Dun &
Bradstreet  will share  liability  equally  for any amounts in excess of the ACN
Maximum Amount.

The ACN Maximum  Amount will be determined by an investment  banking firm as the
maximum  amount which  ACNielsen  is able to pay after giving  effect to (i) any
plan  submitted  by such  investment  bank which is  designed  to  maximize  the
claims-paying  ability of ACNielsen  without  impairing the  investment  banking
firm's  ability to deliver a viability  opinion  (but which will not require any
action  requiring  stockholder  approval),  and (ii) payment of related fees and
expenses.  For  these  purposes,   financial  viability  means  the  ability  of
ACNielsen,  after  giving  effect to such plan,  the payment of related fees and
expenses  and the  payment of the ACN Maximum  Amount,  to pay its debts as they
become due and to finance  the  current and  anticipated  operating  and capital
requirements of its business,  as reconstituted by such plan, for two years from
the date any such plan is expected to be implemented.

Management of the Company is unable to predict at this time the final outcome of
this matter or whether the resolution of the matter could materially  affect the
Company's results of operations, cash flows or financial position.

Note 4 - Financial Instruments with Off-Balance-Sheet Risk

IMS uses  foreign  exchange  forward  contracts  which  provide  for the sale of
foreign currencies to hedge a portion of committed revenues. While these hedging
instruments are subject to fluctuations in value,  such  fluctuations are offset
by changes in the value of the underlying  exposures being hedged. The principal
currencies  hedged are the Japanese Yen, German Mark, Swiss Franc,  Italian Lira
and Spanish  Peseta.  At February  28,  1997,  the  notional  amount  hedged was
$114,000.  These  forward  contracts  are  valued  at  market  quotes  and  have
expiration dates through April 1997.  Gains and losses on forward  contracts and
committed  foreign  currency  revenues  are  deferred  until such  revenues  are
recognized or such commitments are met.

In addition,  foreign exchange forward  contracts are entered into in the normal
course of business to hedge against foreign exchange movements on certain assets
and  liabilities of subsidiaries  that are denominated in currencies  other than
the   subsidiary's   functional   currency.   At  February  28,  1997,  IMS  had
approximately  $92,000 in foreign  exchange forward  contracts  outstanding with
various expiration dates through March 1997.








                                                        -7-

<PAGE>
Note 5 - Adoption of Statements of Financial Accounting Standards

In February 1997, the Financial  Accounting Standards Board issued SFAS No. 128,
"Earnings per Share" ("SFAS No. 128"), which simplifies  existing  computational
guidelines,  revises disclosure  requirements and increases the comparability of
earnings  per share data on an  international  basis.  The Company is  currently
evaluating the new statement; however, the impact of adoption of SFAS No. 128 on
the  Company's  financial  statements  is not expected to be  significant.  This
statement  is  effective  for  financial  statements  for periods  ending  after
December 15, 1997 and  requires  restatement  of all prior  period  earnings per
share data presented.


                                                        -8-
<PAGE>

Item 2. Management's Discussion and Analysis of Financial Condition and 
        Results of Operations
(Dollar amounts in thousands, except per share data)

Reported First Quarter Results

Revenue for the first quarter of 1997 increased  17.5% to $434,701 from $370,019
for the first quarter of the prior year. The increase  reflected  continued high
growth at Gartner  Group,  through  strengthening  of its  product  line and new
product offerings,  strong revenue performance at IMS, and double-digit  revenue
growth at Nielsen Media Research. The increase was partially offset by declining
revenues at Pilot  Software.  The impact of a stronger U.S.  dollar in the first
quarter decreased revenue by approximately 1%.

Operating  income for the first quarter  increased 31.0% to $77,247 from $58,978
for the comparable  period a year ago.  Operating income growth outpaced revenue
growth  primarily due to Gartner  Group's ability to take advantage of economies
of scale and IMS's ability to leverage its  resources.  The impact of a stronger
U.S. dollar in the first quarter decreased operating income by approximately 3%.

Non-operating  income-net  for the first quarter was $555 compared  with 
non-operating  income-net of $446 for the prior year.

The  Company's  effective  tax rate was  32.0% for the  first  quarter  of 1997,
compared with an effective tax rate of 44.0% for the first quarter of 1996.  The
Company has  initiated  global tax  planning  strategies  that have  lowered its
effective tax rate.

The Company's net income for the first quarter  increased  59.0% to $52,905 from
$33,277 in the comparable  period of the prior year.  Earnings per share for the
first quarter increased 55.0% to $.31 from $.20 in the prior year. Net income in
1997 includes an after-tax gain of $3,696,  or $.02 per share,  from the sale of
WEFA Group, Inc., a Cognizant Enterprises venture capital fund investment.

On February  18,  1997 the Company  announced  that its Board of  Directors  had
authorized a systematic stock repurchase program to buy up to 8.5 million shares
of the Company's outstanding common stock over a two-year period.  Through March
31,  1997,  2.8 million  shares  have been  acquired at a total cost of $95,069.
Stock  repurchases  are held in Treasury and reissued  upon exercise of employee
stock options.

Results by Business Segment

The  Marketing  Information  Services  segment  consists of IMS,  Nielsen  Media
Research,  Pilot Software,  Erisco, Cognizant Technology Solutions and Cognizant
Enterprises.  Marketing  Information Services revenue for the first quarter 1997
increased 10.6% to $315,576 from $285,272 in the comparable  period of the prior
year, and up 11.8% excluding the impact of a stronger U.S. dollar. IMS had first
quarter revenue in 1997 of $209,822,  up 9.8% from $191,080 in the first quarter
1996.  Excluding the impact of a stronger  U.S.  dollar,  IMS revenue  increased
11.4%.  IMS revenue  growth  benefited  from a strong  performance  by the Sales
Technologies  unit, market expansion and new product  introductions in the first
quarter.


                                                        -9-

<PAGE>
Results by Business Segment (continued)

Nielsen Media  Research  revenue for the first quarter 1997  increased  12.3% to
$86,271 from $76,821 in the  comparable  period of the prior year. The growth at
Nielsen  Media  Research was driven by the addition of a new metered  market and
the continued impact of new broadcast and cable network  subscribers.  Growth in
the first  quarter 1997 was  adversely  impacted by declining  revenues at Pilot
Software.

Marketing  Information  Services  operating  income for the first  quarter  1997
increased  5.4% to $54,787  from $52,007 in the  comparable  period of the prior
year,  and up 8.9%  excluding  the impact of a stronger  U.S.  dollar.  IMS, the
largest business within this segment,  had first quarter operating income growth
in 1997 of 10.8%.  Excluding the impact of a stronger U.S. dollar, IMS operating
income  increased 16.5%.  Nielsen Media Research  operating income for the first
quarter 1997  increased  11.6%.  Growth in the first  quarter 1997 was partially
offset by a loss at Pilot Software.

The  Information   Technology   Services   segment  consists  of  the  Company's
majority-owned  subsidiary,   Gartner  Group.  Information  Technology  Services
revenue for the first quarter 1997  increased  40.6% to $119,125 from $84,747 in
the  comparable  period  of the  prior  year.  The  growth  reflected  Gartner's
continued  strengthening of its product line and the introduction of new product
offerings.  Information  Technology  Services  operating  income  for the  first
quarter 1997 increased 69.1% to $29,360 from $17,367 in the comparable period of
the prior year.

Condensed Consolidated Statement of Cash Flows
Three Months Ended March 31, 1997 and 1996

     Net cash  provided by operating  activities  totaled  $88,931 for the three
months ended March 31, 1997 compared with $79,400 for the  comparable  period in
1996.  The  increase  of $9,531  principally  reflects  an  increase in business
operating  results  ($19,628),  an  increase in deferred  revenues ($33,768)  at
Gartner Group, lower other working capital items ($47,991)  primarily at IMS and
the absence of  restructuring  payments in 1997  ($8,663).  These  sources  were
partially  offset by an increase in accounts  receivable  in 1997  compared to a
decrease in 1996  ($68,820),  primarily  reflecting  increased sales at IMS and
Gartner Group, and a change in deferred income taxes ($39,613).

Net cash used in investing  activities  totaled  $50,571 for 1997  compared with
$59,223  for the  comparable  period  in 1996.  The  decrease  in cash  used for
investing  activities  of  $8,652  is  principally  due to  lower  payments  for
marketable   securities  ($22,409)  and  proceeds  from  investments   ($7,004),
partially offset by an increase in investments ($16,968).

Net cash used in financing activities totaled $93,631 for the three months ended
in 1997 compared with $19,003 for the comparable period in 1996. The increase in
cash usage of $74,628 is primarily  due to payments for the purchase of treasury
shares ($95,069) and dividends paid ($5,117) in 1997 compared with net transfers
to The Dun & Bradstreet Corporation ($25,591) in 1996.




                                                       -10-

<PAGE>

Changes in Financial Position at March 31, 1997 Compared to December 31, 1996

Cash and Cash Equivalents decreased to $366,005 at March 31, 1997, from $428,520
at December 31, 1996, primarily reflecting the purchase of treasury shares.

Deferred  Revenues  increased  to $339,371 at March 31, 1997,  from  $292,970 at
December 31, 1996,  primarily  reflecting an increase in  subscription  sales at
Gartner Group.

Shareholders'  Equity  decreased to $791,287 at March 31, 1997, from $872,613 at
December  31, 1996,  primarily  reflecting  the purchase of treasury  shares and
change in cumulative translation adjustment, partially offset by net income.



                                                         -11-


<PAGE>
PART II.  OTHER INFORMATION


Item 6. Exhibits and Reports on Form 8-K.

(a)     Exhibits:

        10.  Material Contracts

              .22  Cognizant  Corporation  Retirement  Excess  Plan,  as adopted
                   effective  January 1, 1997 (replaces  Retirement Excess Plan
                   draft filed as Exhibit 10.21 to  Registrant's  Annual Report
                   on Form 10-K for Year Ended  December 31,  1996, filed March
                   28, 1997, file number 001-12275)*

              .23  Cognizant Corporation Savings Equalization Plan, as adopted
                   effective November 1, 1996*

          21.  List of Active Subsidiaries as of January 31, 1997.

(b)     Reports on Form 8-K:

        There were no reports on Form 8-K filed  during the quarter ended 
        March 31, 1997.

- - -----------------------------------------

*Management contract or compensatory plan or arrangement.


                                                         -12-

<PAGE>

                                   SIGNATURES



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                  COGNIZANT CORPORATION




Date: May 13, 1997            By: /s/JAMES C. MALONE
                                  ====================================
                                  James C. Malone
                                  Senior Vice President - Finance & Controller




                                                       -13-



<PAGE>



EXHIBIT 1022




                                    COGNIZANT

                             RETIREMENT EXCESS PLAN



















                         Effective as of January 1, 1997















<PAGE>


============================================================================

============================================================================
                                                      
                              COGNIZANT CORPORATION
                             RETIREMENT EXCESS PLAN

                         Effective as of January 1, 1997


Introduction  

Effective as of January 1, 1997,  the Cognizant  Corporation  Retirement  Excess
Plan (the "Plan") is established  by Cognizant  Corporation  (the  "Company") to
provide  participating  employees  with  retirement  benefits in excess of those
permitted to be paid under the Cognizant  Retirement Plan (the "Qualified Plan")
due to the  limitations  imposed by Sections  401(a)(17) and 415 of the Internal
Revenue  Code of 1986,  as amended  (the  "Code").  For purposes of the Employee
Retirement  Income  Security  Act of 1974,  as amended  ("ERISA"),  this Plan is
intended to be unfunded and  maintained  primarily  for the purpose of providing
deferred  compensation  for a select group of management  or highly  compensated
employees.


<PAGE>


==============================================================================
                     Section I -- Participation in the Plan
==============================================================================


All  participants in the Qualified Plan shall  participate in this Plan whenever
their  benefits  under the  Qualified  Plan as from time to time in effect would
have exceeded the limitations on benefits imposed by Sections 401(a)(17) and 415
of the Code if such  benefits  were  determined  as  though  no  provision  were
contained in the Qualified Plan incorporating such limitations.


<PAGE>


===============================================================================
Section II -- Benefits                
===============================================================================

The Corporation  shall pay to each  participant in the Qualified Plan (or his or
her  beneficiaries  designated to receive  benefits  from the Qualified  Plan) a
benefit equal to the excess of (a) over (b), where:

(a)      equals the amount that would be payable to the  participant  (or his or
         her  beneficiaries)  under the  Qualified  Plan in the  absence  of any
         provision reducing benefits due to the benefit  limitations  imposed by
         Sections 401(a)(17) and 415 of the Code; and

(b)      equals the sum of (i) the actual  benefits  payable to the  participant
         (or his or her  beneficiaries)  from  the  Qualified  Plan and (ii) the
         benefits payable to the participant (or his or her beneficiaries)  from
         the  Pension  Benefit   Equalization  Plan  of  The  Dun  &  Bradstreet
         Corporation  (as in effect on October 31,  1996),  as determined by the
         Company in  accordance  with the methods and  assumptions  specified in
         Appendix A of this Plan.



<PAGE>


===============================================================================
Notwithstanding the foregoing, no benefits shall be payable hereunder unless the
participant  has a  nonforfeitable  right to benefits under the Qualified  Plan.
Benefits hereunder shall be payable at the same time and in the same form as the
participant's (or his or her beneficiaries')  benefits under the Qualified Plan;
provided,  however,  if an Election  (as defined in Section IV of this Plan) has
been made and becomes  effective prior to the date when benefits under this Plan
would otherwise be payable to the  participant,  the form of payment of benefits
under this Plan shall be in the form so elected pursuant to such Election. If an
Election becomes  effective prior to the date when benefits would be payable and
the  participant  dies prior to the date when benefits would be payable,  his or
her  beneficiaries  designated to receive benefits from the Qualified Plan shall
receive  benefits  in the form so  elected  pursuant  to such  Election.  If the
participant has not designated a beneficiary  under the Qualified Plan, or if no
such beneficiary is living at the time of the  participant's  death, the amount,
if any,  payable  hereunder  upon his or her death shall be  distributed  to the
person or persons who would  otherwise be entitled to receive a distribution  of
the participant's Qualified Plan benefits.
===============================================================================

Notwithstanding  any  Election,  if the lump sum value,  determined  in the same
manner as  provided  under  Section  IV below,  of the  benefits  payable to the
participant (or his or her beneficiaries)  under this Plan is $10,000 or less at
the time such  benefits  are payable  under this Plan,  such  benefits  shall be
payable as a lump sum.

Any portion of the benefits  payable under this Plan as a lump sum shall be paid
commencing  at the same time as  benefits  payable in any other  form  hereunder
would otherwise be paid.


<PAGE>


===============================================================================
Section III -- Unfunded Status        
===============================================================================

Participants  hereunder shall have the status of general unsecured  creditors of
the  Company  and this Plan  constitutes  a mere  promise by the Company to make
benefit payments at the time or times required hereunder. It is the intention of
the Company  that this Plan be unfunded  for tax  purposes  and for  purposes of
Title I of ERISA,  and any trust  created by the  Company and any assets held by
such trust to assist the Company in meeting its obligations under the Plan shall
meet the requirements necessary to retain such unfunded status.


<PAGE>


============================================================================
Section IV -- Election of Form of Payment
============================================================================
     (a) A  participant  under this Plan may elect to receive  all,  none,  or a
         specified  portion,  as provided below, of his benefits  hereunder as
         a lump sum and to receive  any  balance  of such  benefits  in the 
         form of an  annuity  (an "Election");  provided that any such Election
         shall be effective for purposes of this Plan only if (i) such 
         participant remains in the employment of the Company or an Affiliate,
         as the case may be, for a period not less than the full 12  calendar
         months  immediately  following the Election Date of such Election 
         except in the case of such participant's death or disability as 
         provided below), and (ii) such participant  complies  with  the  
         administrative  procedures  set  forth  by the Committee with respect
         to the making of an Election.  "Affiliate" shall mean the Company  and
         any  other  employer  which is a member of a  "controlled  group of
         corporations," a group under "common control," or an "affiliated 
         service group,"all as determined under Code Sections 414(b), (c),
         (m), (o).

(b)      Any portion of the benefit  payable to the  participant  (or his or her
         beneficiaries) in the form of an annuity shall be paid at the same time
         and in the same form as his or her benefits  under the Qualified  Plan.
         Any portion of the benefit  payable to the  participant  (or his or her
         beneficiaries)  in the form of a lump sum  shall be paid in full at the
         same time as the benefits  commence  under the Qualified  Plan,  and no
         subsequent lump sum benefits will be paid.

(c)      A participant  may elect a payment form different than the payment form
         previously  elected  by him or her by filing a revised  election  form;
         provided  that any such new  Election  shall be  effective  only if the
         conditions in clauses (i) and (ii) of Section IV(a) above are satisfied
         with  respect  to such  new  Election.  Any  prior  Election  made by a
         participant  that has satisfied such conditions  remains  effective for
         purposes of this Plan until such  participant  has made a new  Election
         satisfying such conditions.

(d)      A participant  making an election under this Section IV may specify the
         portion of his benefits under this Plan to be received in a lump sum as
         follows: 0 percent, 25 percent, 50 percent, 75 percent or 100 percent.


<PAGE>


==============================================================================
(e)      In the event a  participant  who has made an  Election  dies or becomes
         disabled within the meaning of the Company's long-term  disability plan
         while  employed  by the  Company  or an  affiliate  and  such  death or
         disability  occurs  during  the  12-calendar-month  period  immediately
         following the Election Date of such  Election,  the condition that such
         participant  remain  employed with the Company or an affiliate for such
         12-month period shall be deemed to be satisfied and such Election shall
         be effective  with respect to benefits  payable to such  participant or
         participant's beneficiaries under this Plan.
==============================================================================

(f)      The amount of any portion of the  benefits  payable as a lump sum under
         this  Section IV will equal the present  value of such  portion of such
         benefits,  and the  present  value shall be  determined  (i) based on a
         discount  rate equal to the average of 85% of the 15-year  non-callable
         U.S.  Treasury  bond  yields  as of the close of  business  on the last
         business day of each of the three months immediately preceding the date
         the annuity value is  determined  and (ii) using the 1983 Group Annuity
         Mortality Table.

(g)      "Election  Date"  for  purposes  of this  Plan  means  the date  that a
         properly  completed  election  form  with  respect  to an  Election  is
         received by the Company.


<PAGE>


=============================================================================
Section V -- Cessation of Benefits    
=============================================================================

(a)      Notwithstanding  any other  provision  of the Plan  (except as provided
         below in this  Section V), no benefits or no further  benefits,  as the
         case may be, shall be paid to a participant (or his or her beneficiary)
         if the participant has:

        (i)  become a  stockholder  (unless  such  stock is  listed  on a  
             national securities  exchange or traded on a daily basis in the 
             over-the-counter  market and the participant's  ownership interest
             is not in excess of 2% of the company of which the shares are being
             purchased),  employee,  officer, director or consultant of or to a
             Company,  or a member or an employee of or a consultant to a  
             partnership  or any other  business or firm,  which  competes with
             any of the businesses  owned or operated by the Company, or if the
             participant  becomes associated with a company,  partnership or 
             individual which company, partnership or  individual  acts as a  
             consultant  to  businesses in competition with the Company, such 
             participant  provided  services  to such  competing  businesses, 
             whether or not, in any of the foregoing cases, such participant 
             accepts any form of compensation from such competing entity or
             consultant; or

         (ii)   been   discharged  from  employment  with  the  Company  or  any
                affiliate for "cause." "Cause" means (1) willful  malfeasance or
                willful  misconduct by the participant in connection with his or
                her employment, (2) continuing failure to perform such duties as
                are requested by any employee to whom the participant reports or
                the board of directors of the Company,  or (3) the commission by
                a  participant  of  (I)  any  felony  or  (II)  any  misdemeanor
                involving moral turpitude.

(b)      In any case described in this Section V, the participant (or his or her
         beneficiary) shall be given prior written notice that no benefits or no
         further benefits,  as the case may be, will be paid to such participant
         (or his or her  beneficiary).  Such written  notice  shall  specify the
         particular  act(s),  or  failures  to act,  on the  basis of which  the
         decision to cease paying his or her benefits has been made.



<PAGE>


=============================================================================
     (c)  Notwithstanding  any other  provision of the Plan, a  participant  who
          receives in a lump sum any portion of his or her benefits hereunder 
          shall receive such lump sum portion of such benefits  subject to the
          condition that if such  participant  engages in any of the acts
          described in this Section V, then such participant  shall within 60 
          days after written notice by the Company repay to the Company the 
          amount described in the immediately  succeeding sentence. The amount
          described in this sentence shall equal the amount of the participant's
          lump sum benefit under this Plan to which such  participant would not
          have been entitled, if such lump sum benefit had instead been payable
          in the form of an annuity under this Plan and such annuity payments
          were subject to the provisions of this Section V.
============================================================================

     (d) Notwithstanding   anything  to  the  contrary   contained  herein,  the
         provisions  of this  Section V shall be of no  further  force or effect
         from and after a "Change in Control" with respect to participants  then
         employed by the Company or its Affiliates.  For this purpose, a "Change
         in Control" shall mean:

     (i) any  "Person,"  as such term is used for  purposes of Section  13(d) or
         14(d)of the  Securities  Exchange Act of 1934, as amended (the
         "Exchange Act")(other than the Company, any trustee or other fiduciary
         holding securities under an employee  benefit  plan of the  Company,
         or any company  owned,  directly or indirectly,  by the  stockholders 
         of the  Company  in  substantially  the  same proportions as their
         ownership of stock of the Company), becomes the "Beneficial Owner" (as
         defined  in  Rule  13d-3  under  the  Exchange  Act),  directly  or 
         indirectly,  of  securities  of the  Company  representing  20% or  
         more  of the combined voting power of the Company's then-outstanding
         securities;



<PAGE>


===============================================================================
     (ii) during any period of 24 months (not  including any period prior to the
effective  date of this Plan),  individuals  who at the beginning of such period
constitute  the board of  directors of the Company  (the  "Board"),  and any new
director  (other than (a) a director  nominated by a Person who has entered into
an agreement  with the Company to effect a  transaction  described in paragraphs
(i), (iii) or (iv) of this Section V(d), (b) a director  nominated by any Person
(including  the  Company)  who  publicly  announces  an  intention to take or to
consider taking actions (including,  but not limited to, an actual or threatened
proxy contest) which if consummated  would constitute a Change in Control or (c)
a director  nominated  by any Person who is the  Beneficial  Owner,  directly or
indirectly,  of  securities  of the  Company  representing  10% or  more  of the
combined voting power of the Company's  securities)  whose election by the Board
or nomination for election by the Company's stockholders was approved in advance
by a vote of at least  two-thirds  of the  directors  then  still in office  who
either  were  directors  at the  beginning  of the period or whose  election  or
nomination  for election  was  previously  so approved,  cease for any reason to
constitute at least a majority thereof;
===============================================================================

     (iii) the  stockholders of the Company approve any transaction or series of
transactions  under which the Company is merged or  consolidated  with any other
company,  other than a merger or  consolidation  (1) which  would  result in the
voting  securities  of  the  Company   outstanding   immediately  prior  thereto
continuing to represent  (either by remaining  outstanding or by being converted
into voting  securities of the surviving  entity) more than 66% of the combined
voting powers of the voting  securities of the Company or such surviving  entity
outstanding  immediately  after such merger or consolidation and (2) after which
no Person holds 20% or more of the combined voting power of the then-outstanding
securities of the Company or such surviving entity; or

     (iv) the stockholders of the Company approve a plan of complete liquidation
of the Company or an agreement for the sale or disposition by the Company of all
or substantially all of the Company's assets.


<PAGE>


===========================================================================
Section VI -- Funding
===========================================================================

Benefits  payable  under  this Plan shall not be funded and shall be made out of
the general funds of the Company;  provided,  however, that the Company reserves
the right to  establish  one or more  trusts to  provide  alternate  sources  of
benefit  payments under this Plan,  provided,  further,  however,  that upon the
occurrence of a "Potential Change in Control" of the Company,  as defined below,
the appropriate  officers of the Company are required to make  contributions  to
such a trust fund,  established as an alternate source of benefits payable under
the Plan,  as are  necessary to fund the lump sum payments to Plan  participants
required  pursuant to Section V of this Plan in the event of a Change in Control
of the Company; provided,  further, however, that if payments are made from such
trust fund, such payments will satisfy the Company's obligations under this Plan
to the extent made from such trust fund.

In determining the amount of the necessary contribution to the trust fund in the
event of a Potential  Change in Control,  the  following  actuarial  assumptions
shall be used: (i) the interest rate used shall be the interest rate used by the
Pension  Benefit  Guaranty  Corporation  for  determining the value of immediate
annuities  as of  January  1st of the year of the  occurrence  of the  Potential
Change in Control,  (ii) the 1983 Group Annuity  Mortality  Table shall be used;
and (iii) it shall be assumed  that all  participants  will retire or  terminate
employment  with the Company as soon as practicable  after the occurrence of the
Potential Change in Control.

For the purpose of this Plan, "Potential Change in Control" means:

(a)      the Company enters into an agreement, the consumption of which would 
         result in the occurrence of a Change in Control of the Company;

(b)      any person (including the Company) publicly  announces its intention to
         take  or  to  consider  taking  actions  which  if  consummated   would
         constitute a Change in Control of the Company;



<PAGE>


===============================================================================
(c)      any person,  other than a trustee or other fiduciary holding securities
         under an employee benefit plan of the Company (or a corporation  owned,
         directly  or  indirectly,   by  the  stockholders  of  the  Company  in
         substantially  the same  proportions as their ownership of stock of the
         Company),   who  is  or  becomes  the  beneficial  owner,  directly  or
         indirectly,  of securities of the Company  representing 9.5% or more of
         the combined voting power of the Company's then outstanding securities,
         increases his or her beneficial  ownership of such  securities by 5% or
         more over the percentage so owned by such person; or
===============================================================================

(d)      The Board of Directors of the Company adopts a resolution to the effect
         that,  for purposes of this Plan, a Potential  Change in Control of the
         Company has occurred.


<PAGE>


=============================================================================
Section VII -- Miscellaneous          
=============================================================================

(a)      The Compensation and Benefits Committee of the board of directors of 
         the company shall be responsible for the administration of the Plan
         and may delegate to any management committee,  employee,  director or
         agent its responsibility to perform any act hereunder, including 
         without limitation those matters involving the exercise of discretion,
         provided that such  delegation  shall be subject to revocation at any
         time at the Committee's  discretion.  The Committee shall have the 
         authority to determine all questions arising in connection with the 
         Plan, to interpret the provisions of the Plan and construe all of its
         terms,  to adopt, amend, and rescind rules and regulations for the 
         administration of the Plan, and generally to conduct and administer
         the Plan and to make all  determinations in connection  with the Plan
         as may be necessary or advisable.  All such actions of the  Committee
         shall  be  conclusive  and  binding  upon all  participants and 
         beneficiaries.

(b)      The Committee may, in its sole discretion,  terminate, suspend or amend
         this  Plan at any  time or from  time to  time,  in  whole  or in part;
         provided,  however,  that in the event of  termination,  the  rights of
         participants   to  their  accrued   benefits   hereunder  shall  become
         nonforfeitable. No termination, suspension or amendment of the Plan may
         adversely affect a participant's  or beneficiary's  benefit to which he
         or she is entitled under the Plan as in effect on the date  immediately
         preceding the date of such termination, suspension or amendment.

(c)      Nothing  contained herein will confer upon any participant the right to
         be retained in the service of the Company or any affiliate, nor will it
         interfere  with the right of the Company or any  affiliate to discharge
         or  otherwise  deal  with  participants  with  respect  to  matters  of
         employment.

(d)      A participant's  right to benefit  payments under the Plan shall not be
         subject  in any manner to  anticipation,  alienation,  sale,  transfer,
         assignment, pledge, encumbrance, attachment or garnishment by creditors
         of such participant or his or her beneficiary.



<PAGE>


============================================================================
(e)      The Company may withhold from any benefit under the Plan an amount
         sufficient to satisfy its tax withholding obligations.
=============================================================================

(f)      The Plan shall be governed by and construed in accordance with the laws
         of the  State  of New  York  applicable  to  contracts  made  and to be
         performed in such state to the extent not preempted by federal law.



<PAGE>


==============================================================================
                                   APPENDIX A
==============================================================================

The benefits  payable from the Pension  Benefit  Equalization  Plan of The Dun &
Bradstreet  Corporation  (the  "PBEP")  to  participants  of this Plan  shall be
determined  as  amounts  payable  monthly in the form of a single  life  annuity
commencing on the first day of the month  coincident  with or next following the
date the participant attains age 65 (the "Normal Retirement Date").

In the event a participant's benefit from this Plan is paid in a form other than
a single life  annuity,  however,  the  benefits  payable from the PBEP shall be
adjusted to equal the  actuarial  equivalent  value of the single  life  annuity
amount computed on the basis of mortality rates shown in Appendix B of this Plan
and  6.75%  interest.  In the  event a  participant's  benefit  from  this  Plan
commences prior to the participant's Normal Retirement Date, and the participant
terminated  employment  with the Company on or after he or she  attained age 55,
the  benefits  payable  from the PBEP  commencing  on the first day of the month
coincident with or next following the participant's Normal Retirement Date shall
be reduced by 3/12% for each month prior to the Normal  Retirement  Date (or age
60 if the  participant  has 35 years of service  on his or her Early  Retirement
Date) that benefits  commence.  In the event a  participant's  benefit from this
Plan  commences  prior to the  participant's  Normal  Retirement  Date,  and the
participant terminated employment with the Company before he or she attained age
55, the benefits  payable from the PBEP as  determined  in  accordance  with the
provisions  set forth above shall be adjusted to equal the actuarial  equivalent
value of such amount  computed on the basis of mortality rates shown in Appendix
B of this Plan and 6.75% interest.


<PAGE>


=============================================================================
                                   APPENDIX B
=============================================================================
<TABLE>
                                 MORTALITY RATES
<CAPTION>
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
Age                   Participant        Beneficiary        Age                Participant        Beneficiary
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
<S>     <C>                <C>                <C>               <C>               <C>                 <C>
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
25                    .000581            .000470            68                 .024559            .018359
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
26                    .000610            .000497            69                 .026871            .020335
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
27                    .000644            .000526            70                 .029559            .022766
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
28                    .000681            .000557            71                 .032952            .025919
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
29                    .000720            .000591            72                 .036762            .029529
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
30                    .000763            .000629            73                 .040907            .033496
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
31                    .000811            .000669            74                 .045427            .037808
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
32                    .000866            .000714            75                 .050298            .042428
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
33                    .000923            .000762            76                 .055809            .047551
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
34                    .000988            .000814            77                 .062080            .053217
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
35                    .001059            .000873            78                 .069068            .059419
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
36                    .001136            .000936            79                 .076746            .066152
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
37                    .001223            .001077            80                 .084955            .073330
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
38                    .001318            .001084            81                 .093582            .080901
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
39                    .001423            .001168            82                 .102603            .088868
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
40                    .001539            .001261            83                 .111984            .097236
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
41                    .001682            .001369            84                 .121754            .106074
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
42                    .001869            .001497            85                 .131910            .115436
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
43                    .002097            .001647            86                 .142522            .125403
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
44                    .002364            .001815            87                 .153693            .136075
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
45                    .002670            .002005            88                 .165518            .147557
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
46                    .003011            .002216            89                 .178093            .159954
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
47                    .003388            .002449            90                 .191529            .173397
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
48                    .003797            .002705            91                 .203702            .185997
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
49                    .004241            .002983            92                 .216646            .199614
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
50                    .004717            .003289            93                 .230478            .214387
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
51                    .005216            .003594            94                 .245331            .230463
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
52                    .005746            .003926            95                 .261353            .248008
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
53                    .006310            .004288            96                 .278704            .267202
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
54                    .006907            .004683            97                 .297562            .288242
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
55                    .007538            .005112            98                 .318124            .311344
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
56                    .008206            .005588            99                 .340598            .336741
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
57                    .008916            .006123            100                .365204            .364688
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
58                    .009679            .006729            101                .392179            .395460
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
59                    .010510            .007415            102                .421772            .429358
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
60                    .011426            .008190            103                .455805            .467222
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
61                    .012449            .009063            104                .496440            .510917
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
62                    .013608            .010042            105                .545840            .562310
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
63                    .014928            .011131            106                .606167            .623265
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
64                    .016449            .012338            107                .679585            .695646
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
65                    .018207            .013671            108                .768255            .781319
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
66                    .020245            .015129            109                .874340            .882150
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------
67                    .022388            .016662            110                .999999            .999999
- - --------------------- ------------------ ------------------ ------------------ ------------------ ------------------

</TABLE>

<PAGE>

Table of Contents                                                     Page

Introduction............................................................1
Section I -- Participation in the Plan..................................2
Section II -- Benefits..................................................3
Section III -- Unfunded Status..........................................5
Section IV -- Election of Form of Payment...............................6
Section V -- Cessation of Benefits......................................8
Section VI -- Funding..................................................11
Section VII -- Miscellaneous...........................................13


<PAGE>


EXHIBIT 1023
                          COGNIZANT CORPORATION SAVINGS
                                EQUALIZATION PLAN

I.       Purpose of the Plan

                  The purpose of the Cognizant  Corporation Savings Equalization
Plan (the  "Plan") is to provide a means of  equalizing  the  benefits  of those
employees  participating in the Cognizant  Corporation Savings Plan (the "401(k)
Plan") whose matching contributions under the 401(k) Plan are or will be limited
by the application of sections 401(a)(17) or 415 of the Internal Revenue Code of
1986,  as amended (the  "Code").  The Plan is intended to be an "excess  benefit
plan" as that term is defined in section 3(36) of the Employee Retirement Income
Security Act of 1974, as amended  ("ERISA")  with respect to those  participants
whose  benefits  under the 401(k)  Plan have been  limited by Section 415 of the
Code,  and a plan which is unfunded and is maintained  by an employer  primarily
for the  purposes  of  providing  deferred  compensation  for a select  group of
management or highly compensated employees for purposes of ERISA.

II.      Administration of the Plan

                  The  Compensation  Committee  of the Board of  Directors  (the
"Committee") of Cognizant Corporation (the "Corporation" or the "Company") shall
administer  the Plan and may delegate to any  committee,  employee,  director or
agent  its  responsibility  to  perform  any act  hereunder,  including  without
limitation  those matters  involving the exercise of  discretion,  provided that
such  delegation  shall be subject to revocation at any time at its  discretion.
The Committee  shall have full  authority to determine all questions  arising in
connection with the Plan, other than those determinations delegated to employees
or independent third parties by the Board of Directors,  including  interpreting
its provisions and construing all of its terms; may adopt procedural  rules; and
may employ and rely on such legal counsel, such actuaries,  such accountants and
such  agents as it may deem  advisable  to assist in the  administration  of the
Plan.  All of its rules,  interpretations  and  decisions  shall be applied in a
uniform  manner to all  participants  similarly  situated  and  decisions of the
Committee shall be conclusive and binding on all persons.

III.     Participation in the Plan

                  All   members  of  the  401(k)   Plan  shall  be  eligible  to
participate  in this Plan whenever  their benefits under the 401(k) Plan as from
time  to  time  in  effect  would  exceed  the   limitations   on  benefits  and
contributions imposed by sections 401(a)(17) or 415 of the Code. For purposes of
this Plan,  benefits of a participant in this Plan shall be determined as though
no provision were contained in the 401(k) Plan incorporating limitations imposed
by Sections 401(a)(17) or 415 of the Code.

IV.  Equalized Benefits

                  If member participating contributions or Company contributions
to the 401(k)  Plan are  suspended  during any  calendar  year  because any such
contributions  would cause the  participant's  account under such plan to exceed
the benefit limitations related to such plan as described in Section III of this
Plan, the Corporation  shall pay the  participant,  on or about March 1st of the
following year, an amount equal to:

                  (1) the Company  matching  contributions  that otherwise would
                  have been  credited to such  participant's  account  under the
                  401(k)  Plan  for  the  balance  of the  year  in  which  such
                  suspension  occurs,  as if no provision were set forth therein
                  incorporating limitations imposed by section 401(a)(17) or 415
                  of the Code,  and the  participant  had continued his elective
                  deferrals to the 401(k) Plan at the rate in effect at the time
                  such  contributions were suspended for the balance of the year
                  in which such suspension occurs, plus

                  (2) an interest  factor equal to one-half of the annual return
                  which  would have been  received by the  participant  had such
                  payment  been  invested  eighty  percent  (80%) in the Special
                  Fixed  Income  Fund  (Fund C) of the  401(k)  Plan and  twenty
                  percent  (20%) in the BZW  Equity  Index  Fund (Fund A) of the
                  401(k) plan during the year which such suspension occurs, less

                  (3) any applicable withholding taxes.

V.       Miscellaneous

                  This  Plan  may be  terminated  at any  time by the  Board  of
Directors of the Corporation, in which event the rights of participants to their
accrued benefits shall become  nonforfeitable.  This Plan may also be amended at
any time by the  Board of  Directors  of the  Corporation,  except  that no such
amendment shall deprive any participant of benefits  accrued at the time of such
amendment.

                  Benefits payable under this Plan shall not be funded and shall
be made out of the general funds of the Corporation; provided, however, that the
Corporation  reserves the right to establish a trust fund as an alternate source
of benefits payable under the Plan and to the extent payments are made from such
trust, such payments will satisfy the Corporation's obligations under this Plan.

                  No right to payment or any other  interest under this Plan may
be  alienated,  sold,  transferred,   pledged,  assigned,  or  made  subject  to
attachment, execution, or levy of any kind.

                  Nothing in this Plan shall be construed as giving any employee
the right to be  retained  in the  employ of the  Corporation.  The  Corporation
expressly  reserves the right to dismiss any employee at any time without regard
to the effect which such dismissal might have upon him under the Plan.

                  This  Plan  shall  be  construed,  administered  and  enforced
according to the laws of the State of  Connecticut  unless  preempted by federal
law.

VI.  Effective Date

                  This Plan shall be effective as of the date on which shares of
common stock of the Company and ACNielsen  Corporation that are owned by The Dun
& Bradstreet  Corporation  ("D&B") are  distributed  to the holders of record of
shares of D&B.



<PAGE>


                         EXHIBIT 21B
                    Cognizant Corporation
             Active Subsidiaries as of January 31, 1997

<TABLE>
<CAPTION>
                                                               State of Other      %Ownership
                                                                Jurisdiction       100%except
          Name                                                  Incorporation       as noted
- - ---------------------------------------------------------------------------------------------
<S>                                                                    <C>             <C> 
COGNIZANT ENTERPRISES, INC.                                              Delaware
COGNIZANT HOLDING CORPORATION                                            Delaware

COGNIZANT INDIA HOLDING CORPORATION                                      Delaware
         CZT India Corporation                                           Delaware

COGNIZANT JAPAN K.K.                                                     Japan
         SSJ K.K.                                                        Japan
         IMS Japan Ltd. KK                                               Japan
         Nippon Computer Services, Inc.                                  Japan

COGNIZANT SOFTWARE SOLUTIONS CORPORATION                                 Delaware
         Cognizant Technology Solutions Corporation                      Delaware
         Cognizant Technology Solutions Canada, Inc.                     Canada
         Dun & Bradstreet-Satyam Software Private Limited                India          76.0
         CSS Investment Corporation                                      Delaware
         Dun & Bradstreet India Private Limited                          India          99.0
              Dun & Bradstreet Marketing Research Private Limited        India          70.0

COGNIZANT TRANSPORTATION SERVICES CORPORATION                            Delaware

CZT/ACN TRADEMARKS,  L.L.C.                                              Delaware       50.0

DBHC, INC.                                                               Delaware
         LexHealth, Inc.                                                 Illinois

ERISCO, INC.                                                             New York

GARTNER GROUP, INC.                                                      Delaware       52.3
         Gartner Group Pacific Pty Limited                               Australia
         Gartner Group Scandinavia, A/S                                  Denmark
         Gartner Group UK Ltd.                                           United Kingdom
         Gartner Group France S.A.R.L.                                   France
         Gartner Group, GmbH                                             Germany
         Gartner Group Italia S.r.l.                                     Italy
              Nomos Ricerca Services S.r.l.                              Italy
                  Nomos Ricerca S.r.l                                    Italy
                  Nomos Ricerca Telecomunicazioni S.r.l.                 Italy
         Gartner Group Japan KK                                          Japan
         Gartner Group Nederland B.V.                                    Netherlands
         Gartner Group Europe Holding B.V.                               Netherlands
         Gartner Group Norge, A/S                                        Norway
         Gartner Group Sverige AB                                        Sweden
         Gartner Group Asia, Inc.                                        Delaware
         Gartner Credit Corporation                                      Delaware
         Gartner Group Europe, Inc.                                      Delaware
         Gartner Group Sales, Inc.                                       Delaware

<PAGE>

GARTNER GROUP, INC.  (Continued)
         GG Hong Kong, Inc.                                              Delaware
         G.G. Investment Management, Inc.                                Delaware
                  G.G. West Corporation                                  Delaware
         Gartner Enterprises, Ltd                                        Delaware
                  Decision Drivers, Inc.                                 Delaware        81.3
         New Science Associates, Ltd.                                    United Kingdom
         New Science Limited                                             United Kingdom
         Dataquest Incorporated                                          California
                  Dataquest Asia Pacific Limited                         Hong Kong
                           DQ Research Pte. Ltd                          Singapore
                           Dataquest Taiwan Limited                      Taiwan
                           Dataquest Research (Thailand) Limited         Thailand
                  Dataquest Japan Limited                                Japan
                  Dataquest (Korea) Inc.                                 Delaware
         Gartner Group FSC, Inc.                                         Virgin Islands
         Gartner Group Learning, Inc.                                    Minnesota
                  J3 Learning Limited                                    United Kingdom
         Mindware Training Technologies, Ltd.                            Ireland

IMS HOLDINGS (U.K.) LIMITED                                              United Kingdom
         Intercontinental Medical Statistics Ltd.                        United Kingdom
                  Imsworld Publications Ltd.                             United Kingdom
         IMS Sold Out Limited                                            United Kingdom
         Medical Direct Mail Organisation Ltd.                           United Kingdom 
         PMS International Limited                                       United Kingdom
         Pharma Strategy Group Limited                                   United Kingdom
         ST Europe Ltd.                                                  United Kingdom
                  S.T. S.A.R.L.                                          France

I.M.S. INTERNATIONAL, INC.                                               Delaware
         IMS Australia Pty. Ltd.                                         Australia
                  Amfac Pty. Limited                                     Australia
                  Chemdata Pty. Limited                                  Australia
                           Data Design Hisoft Pty. Limited               Australia           50.0
                           Medrecord Australia Pty. Limited              Australia
                  Permail Pty. Limited                                   Australia
                  Healthnet Pty. Limited                                 Australia
         IMS of Canada Limited                                           Canada
         IMS Pacific Limited                                             Hong Kong
         IMS Korea Ltd.                                                  Korea
         IMS (NZ) Limited                                                New Zealand
         I.M.S. Portugal-Consultores Internacionais
             de Marketung Farmaceutico, Lda.                             Portugal
         IMS International (South Africa)(Pty.)Ltd.                      South Africa
         I.M.S. Financial, Inc.                                          Delaware
                  Dun & Bradstreet Germany Holding GmbH                  Germany
                           IMS-MIDOC Medizinische Informations, Doku-
                              mentations und Consultinggesellschaft mbH  Germany

<PAGE>
I.M.S. INTERNATIONAL, INC. (Continued)
                                  IMS Holding Deutschland GmbH           Germany
                                        IFNS Marktforschung Gmb          Germany
                                        IMS GmbH Institut fur 
                                        Medizinische Statistik           Germany
                                            IMS Data GmbH                Germany
                                            IMS Hellas Ltd.              Greece       50.0
                                            GPI Krankenhausforschung     Germany      60.0
                                            Gesellschaft Fur Pharma- 
                                            Informationssysteme m.b.H.
                                        MedVantage GmbH Integriertes     Germany      60.0
                                        Datenmanagement im Health 
                                        Care-Markt
          Data Coordination (Israel) Ltd.                                Israel
          IMS Asia (1989) Pte. Ltd.                                      Singapore
          IMS Pharminform Holding AG                                     Switzerland  99.85
               Duns Licensing Associates, L.P.                           Delaware     42.77
                      Spartan Leasing Corporation                        Delaware
                      Corinthian Leasing Corporation                     Delaware
               Pharmadat Marktforschungs-Gesellschaft m.b.H.             Austria
                      Pharmacall Statistik Ges. m.b.H.                   Austria
               Informations Medicales Et Statistiques S.A.               Belgium
               Pharma Data Boliviana S.R.L                               Bolivia
               IMS Servicos Ltda.                                        Brazil      96.83
               Intercomunicaciones Y Servicio de Datos S.A.
                 [a/k Interdata S.A.]                                    Colombia    94.96
               IMS Medinform A.S.                                        Czech Republic
               IMS Republica Dominicana S.A.                             Dominican Republic
               Datandina Ecuador S.A.                                    Ecuador
               IMS Egypt Limited                                         Egypt       99.99
               Institute for Medical Statistics Oy                       Finland
               Asserta Centroamerica Medicion de Mercados, S.A.          Guatemala
               IMS Medinform Hungaria Market Research Services Ltd.      Hungary
               IMS Data (M) Sdn. Bhd.                                    Malaysia
               Interdata S.A. de C.V.                                    Mexico
               Informations Medicales & Statistiques S.A.R.L.            Morocco
               I.M.S. (Nederland) B.V.                                   Netherlands
                         IMS Denmark ApS                                 Denmark
                         Informations Medicales Et Statistiques SA       France      75.00
               I.M.S. Finance (Nederland) B.V.                           Netherlands
               Institute for Medical Statistics Norge A/S                Norway
               Pharma Data Paraguaya S.R.L.                              Paraguay
               Datandina S.A.                                            Peru
               Intercontinental Marketing Services Iberica, S.A.         Spain
               Mercados Y Analisis, S.A. [a/k MASA]                      Spain
               Data Coordination AG                                      Switzerland
                         PMA Sociedad Anonima                            Argentina
               IMS AG                                                    Switzerland
               IMS Information Medical Statistics AG                     Switzerland
                         IMS Poland Limited Sp. z.o.o.                   Poland

<PAGE>
I.M.S. INTERNATIONAL, INC. (Continued)
                         IMS Sweden AB                                   Sweden
                  RCI Research Consultants AG                            Switzerland
                         Marketing Y Datos Limitada[a/k Markdata Ltda.]  Chile       99.99
                  Interstatistik AG                                      Switzerland
                         IMS Ges m.b.H.                                  Austria
                         Datec Industria e Comercio, 
                         Distribuidora Grafica                           Brazil      99.99
                         e Mala Direta Ltda.
                  IMS Tunisia                                            Tunisia
                  IMS Tibbi Istatistik Ticaret ve Musavirlik 
                  Ltd Sirketi [a/k IMS Turkiye Ltd.]                     Turkey
                  Pharma Data Uruguaya S.A.                              Uruguay
                  PMV De Venezuela, C.A.                                 Venezuela
              Medicare Audit Limited                                     United Kingdom 50.00
         Clark-O'Neill, Inc.                                             New Jersey
         IMS America, Ltd.                                               New Jersey
                  Coordinated Management Systems, Inc.                   Delaware
         IMS Software Services, Ltd.                                     Delaware
         Intercontinental Medical Statistics International, Ltd.         Delaware
         Intercontinental Medical Statistics International, Ltd.         New York
         Media Management Systems,  Inc.                                 Delaware
         PJH Technology Solutions, Ltd.                                  Delaware
                  Decision Surveys International (Pty.) Ltd.             South Africa
                           IMSA (Pty.) Ltd.                              South Africa
                           IPRA (Pty.) Ltd.                              South Africa
                           PMSA (Pty.) Ltd.                              South Africa

IMS SERVICES NEDERLAND B.V.                                              Netherlands

IMS ITALIA S.p.A.                                                        Italy         55.08%
         IMS Holding (Belgium) S.A.                                      Belgium
PILOT SOFTWARE, INC.                                                     Delaware
         PES (Amsterdam) Holding en Finance B.V.                         Netherlands
                  Pilot Software Pty. Ltd.                               Australia
                  Pilot Software Ltd.                                    United Kingdom
                           Thorn EMI Computer Software Ltd.              United Kingdom
                  Pilot Software S.A.R.L.                                France
                  Pilot Software GmbH                                    Germany
                  Pilot Software S.R.L.                                  Italy
                  Pilot Software B.V.                                    Netherlands
                  Pilot Software Pte. Ltd.                               Singapore
                  Pilot Software AB                                      Sweden

NIELSEN MEDIA RESEARCH, INC.                                             Delaware
         Media Licensing Associates, Inc.                                Delaware

NIELSEN MEDIA RESEARCH LTD.                                              Canada

SALES TECHNOLOGIES, INC.                                                 Georgia
         Aurum Software, Inc.                                            California

</TABLE>









<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                         366,005
<SECURITIES>                                    26,651
<RECEIVABLES>                                  457,699
<ALLOWANCES>                                    14,757
<INVENTORY>                                     27,954
<CURRENT-ASSETS>                               942,823
<PP&E>                                         579,344
<DEPRECIATION>                                 311,971
<TOTAL-ASSETS>                               1,820,726
<CURRENT-LIABILITIES>                          705,927
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         1,703
<OTHER-SE>                                     789,584
<TOTAL-LIABILITY-AND-EQUITY>                 1,820,726
<SALES>                                        434,701
<TOTAL-REVENUES>                               434,701
<CGS>                                                0
<TOTAL-COSTS>                                  357,454
<OTHER-EXPENSES>                                 4,365
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 450
<INCOME-PRETAX>                                 77,802
<INCOME-TAX>                                    24,897
<INCOME-CONTINUING>                             52,905
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    52,905
<EPS-PRIMARY>                                      .31
<EPS-DILUTED>                                      .31
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission